Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53AIP1 expression can be a prognostic marker in non-small cell lung cancer.

Clinical oncology (Royal College of Radiologists (Great Britain)) - 1 Mar 2008

Yamashita S-I, Masuda Y, Yoshida N, Matsuzaki H, Kurizaki T, Haga Y, Ikei S, Miyawaki M, Kawano Y, Chujyo M, Kawahara K

Abstract excerpt

AIMS: p53AIP1 is a potential mediator of p53-dependent apoptosis that is mutated in many kinds of carcinoma. To investigate the role of this gene for non-small cell lung cancer, we compared the relationship between p53AIP1 gene expression and clinicopathological status of lung cancer. MATERIALS AND METHODS: Seventy samples from non-small cell lung cancer patients were obtained between 1997 and 2003. For...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Apoptosis Regulatory Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to Genes, p53

Share to Lymphatic Metastasis

Share to Polymorphism, Single-Stranded Conformational

Share to Smoking

Share to Survival Analysis

Source

Identifiers

PMID: 17851056
DOI: 10.1016/j.clon.2007.08.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53AIP1 expression can be a prognostic marker in non-small cell lung cancer.PMID 17851056Read ↗

Combination of p53AIP1 and survivin expression is a powerful prognostic marker in non-small cell lung cancerSemantic proximity Read ↗

Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis.Semantic proximity Read ↗

Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer.Semantic proximity Read ↗

Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers.Semantic proximity Read ↗

Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.Semantic proximity Read ↗

p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study.Semantic proximity Read ↗

Insulin‐like growth factor binding protein‐related protein 1 (IGFBP‐rP1) has potential tumour‐suppressive activity in human lung cancerSemantic proximity Read ↗

Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma.Semantic proximity Read ↗

Survivin expression impacts prognostically on NSCLC but not SCLC.Semantic proximity Read ↗

Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.Semantic proximity Read ↗

The prognostic role of tissue and serum MMP-1 and TIMP-1 expression in patients with non-small cell lung cancerSemantic proximity Read ↗

p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.